A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy
-
Enrollment
This study is currently enrolling. -
Research Area
Clinical Cancer Research -
Sponsor
Deciphera Pharmaceuticals, LLC
Enrollment Form
This study is currently enrolling.